{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T20:32:51Z","timestamp":1783801971976,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81622047"],"award-info":[{"award-number":["81622047"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81473334"],"award-info":[{"award-number":["81473334"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Liaoning Bai Qian Wan Talents Program"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.toxlet.2018.05.008","type":"journal-article","created":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T12:31:02Z","timestamp":1525869062000},"page":"27-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["Drug interaction study of flavonoids toward CYP3A4 and their quantitative structure activity relationship (QSAR) analysis for predicting potential effects"],"prefix":"10.1016","volume":"294","author":[{"given":"Yannan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengpeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokui","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenlong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baojing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangge","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2018.05.008_bib0005","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1124\/jpet.114.216838","article-title":"Assessment of a candidate marker constituent predictive of a dietary substance-drug interaction: case study with grapefruit juice and CYP3A4 drug substrates","volume":"351","author":"Ainslie","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.toxlet.2018.05.008_bib0010","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0076-6879(96)72016-5","article-title":"Assays of omeprazole metabolism as a substrate probe for human CYP isoforms","volume":"272","author":"Birkett","year":"1996","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.toxlet.2018.05.008_bib0015","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.2174\/138955708786369564","article-title":"Flavonoids: prospective drug candidates","volume":"8","author":"Cazarolli","year":"2008","journal-title":"Mini Rev. Med. Chem"},{"key":"10.1016\/j.toxlet.2018.05.008_bib0020","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/bdd.1905","article-title":"Effects of licochalcone A on the bioavailability and pharmacokinetics of nifedipine in rats: possible role of intestinal CYP3A4 and P-gp inhibition by licochalcone A","volume":"35","author":"Choi","year":"2014","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.toxlet.2018.05.008_bib0025","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1208\/s12248-016-9945-7","article-title":"Metabolic profile of 3-Acetyl-11-Keto-\u03b2-Boswellic acid and 11-Keto-\u03b2-Boswellic acid in human preparations in vitro, species differences, and bioactivity variation","volume":"18","author":"Cui","year":"2016","journal-title":"Aaps J."},{"key":"10.1016\/j.toxlet.2018.05.008_bib0030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijantimicag.2011.02.014","article-title":"Recent advances in understanding the antibacterial properties of flavonoids","volume":"38","author":"Cushnie","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.toxlet.2018.05.008_bib0035","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/mnfr.200600173","article-title":"Overview of antibacterial, antitoxin, antiviral, and antifungal activities of tea flavonoids and teas","volume":"51","author":"Friedman","year":"2007","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.toxlet.2018.05.008_bib0040","doi-asserted-by":"crossref","first-page":"9779","DOI":"10.1039\/c3cc45250f","article-title":"A highly selective probe for human cytochrome P450 3A4: isoform selectivity, kinetic characterization and its applications","volume":"49","author":"Ge","year":"2013","journal-title":"Chem. Commun."},{"key":"10.1016\/j.toxlet.2018.05.008_bib0045","doi-asserted-by":"crossref","first-page":"9779","DOI":"10.1039\/c3cc45250f","article-title":"A highly selective probe for human cytochrome P450 3A4: isoform selectivity, kinetic characterization and its applications","volume":"49","author":"Ge","year":"2013","journal-title":"Chem. Commun. (Camb)"},{"key":"10.1016\/j.toxlet.2018.05.008_bib0050","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jchromb.2016.12.006","article-title":"Highly sensitive LC\u2013MS\/MS methods for the determination of seven human CYP450 activities using small oral doses of probe-drugs in human","volume":"1040","author":"Grangeon","year":"2017","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.toxlet.2018.05.008_bib0055","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.yclnex.2015.09.001","article-title":"The value of flavonoids for the human nutrition: short review and perspectives","volume":"3","author":"Hoensch","year":"2015","journal-title":"Clin. Nutr. Exp."},{"key":"10.1016\/j.toxlet.2018.05.008_bib0060","first-page":"1","article-title":"Influence of grapefruit juice on pharmacokinetics of triptolide in rats grapefruit juice on the effects of triptolide","author":"Jia","year":"2017","journal-title":"Xenobiotica"},{"key":"10.1016\/j.toxlet.2018.05.008_bib0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.toxlet.2016.09.004","article-title":"The natural anthraquinones from rheum palmatum induced the metabolic disorder of melatonin by inhibiting human CYP and SULT enzymes","volume":"262","author":"Jiang","year":"2016","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.toxlet.2018.05.008_bib0070","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1016\/j.xphs.2017.03.010","article-title":"Small-dosing clinical study: pharmacokinetic, pharmacogenomic (SLCO2B1 and ABCG2), and interaction (Atorvastatin and grapefruit juice) profiles of five probes for OATP2B1 and BCRP","volume":"106","author":"Kashihara","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.toxlet.2018.05.008_bib0075","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1021\/jm0489713","article-title":"Predictive three-dimensional quantitative structure-activity relationship of cytochrome P450 1A2 inhibitors","volume":"48","author":"Korhonen","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.toxlet.2018.05.008_bib0080","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/mrc.2274","article-title":"NMR spectral assignments of isoprenylated flavanones from Sophora tonkinensis","volume":"46","author":"Li","year":"2008","journal-title":"Magn. Reson. Chem."},{"key":"10.1016\/j.toxlet.2018.05.008_bib0085","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.phytol.2008.08.001","article-title":"Isoprenylated flavonoids from the roots of Sophora tonkinensis","volume":"1","author":"Li","year":"2008","journal-title":"Phytochem. Lett."},{"key":"10.1016\/j.toxlet.2018.05.008_bib0090","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/mrc.2281","article-title":"Structural determination of flavonoids from sorphora flavescens","volume":"46","author":"Ma","year":"2008","journal-title":"Magn. Reson. Chem."},{"key":"10.1016\/j.toxlet.2018.05.008_bib0095","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2174\/1381612820666141014124319","article-title":"Inhibitory effect of ebselen on cerebral acetylcholinesterase activity in vitro: kinetics and reversibility of inhibition","volume":"21","author":"Martini","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.toxlet.2018.05.008_bib0100","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1124\/dmd.114.058040","article-title":"The revised human liver cytochrome P450 \"Pie\": absolute protein quantification of CYP4F and CYP3A enzymes using targeted quantitative proteomics","volume":"42","author":"Michaels","year":"2014","journal-title":"Drug Metab. Dispos. Biol. Fate Chem."},{"key":"10.1016\/j.toxlet.2018.05.008_bib0105","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1124\/dmd.105.008672","article-title":"The human intestinal cytochrome P450 \"pie\"","volume":"34","author":"Paine","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.toxlet.2018.05.008_bib0110","doi-asserted-by":"crossref","DOI":"10.1017\/jns.2016.41","article-title":"Flavonoids: an overview","volume":"5","author":"Panche","year":"2016","journal-title":"J. Nutr. Sci."},{"key":"10.1016\/j.toxlet.2018.05.008_bib0115","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3109\/00498254.2015.1036954","article-title":"A comprehensive assay for nine major cytochrome P450 enzymes activities with 16 probe reactions on human liver microsomes by a single LC\/MS\/MS run to support reliable in vitro inhibitory drug-drug interaction evaluation","volume":"45","author":"Peng","year":"2015","journal-title":"Xenobiotica"},{"key":"10.1016\/j.toxlet.2018.05.008_bib0120","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/03602539709037591","article-title":"Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors","volume":"29","author":"Rendic","year":"1997","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.toxlet.2018.05.008_bib0125","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.toxlet.2016.07.023","article-title":"Inhibition of human and rat CYP1A1 enzyme by grapefruit juice compounds","volume":"258","author":"Santespalacios","year":"2016","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.toxlet.2018.05.008_bib0130","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/ptr.5447","article-title":"Recent trends in preclinical drug-drug interaction studies of flavonoids-review of case studies, issues and perspectives","volume":"29","author":"Srinivas","year":"2015","journal-title":"Phytother Res."},{"key":"10.1016\/j.toxlet.2018.05.008_bib0135","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/ptr.5447","article-title":"Recent trends in preclinical drug-drug interaction studies of flavonoids-review of case studies, issues and perspectives","volume":"29","author":"Srinivas","year":"2015","journal-title":"Phytother. Res."},{"key":"10.1016\/j.toxlet.2018.05.008_bib0140","first-page":"521","article-title":"Flavonoids in foods: a review","volume":"10","author":"Terahara","year":"2015","journal-title":"Nat. Product Commun."},{"key":"10.1016\/j.toxlet.2018.05.008_bib0145","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1146\/annurev.pharmtox.38.1.389","article-title":"In vitro and in vivo drug interactions involving human CYP3A","volume":"38","author":"Thummel","year":"1998","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.toxlet.2018.05.008_bib0150","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1111\/bph.13612","article-title":"Inhibition of melatonin metabolism in humans induced by chemical components from herbs and effective prediction of this risk using a computational model","volume":"173","author":"Wang","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.toxlet.2018.05.008_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S000711451300278X","article-title":"Flavonoid intake and risk of CVD: a systematic review and meta-analysis of prospective cohort studies","volume":"111","author":"Wang","year":"2014","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.toxlet.2018.05.008_bib0160","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1365-2125.2006.02755.x","article-title":"The effect of St John's wort extracts on CYP3A: a systematic review of prospective clinical trials","volume":"62","author":"Whitten","year":"2006","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.toxlet.2018.05.008_bib0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075604","article-title":"Dietary flavonoid intake and smoking-related cancer risk: a meta-analysis","volume":"8","author":"Woo","year":"2013","journal-title":"Plos One"},{"key":"10.1016\/j.toxlet.2018.05.008_bib0170","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1124\/jpet.110.175356","article-title":"Three-dimensional quantitative structure-activity relationship studies on UGT1A9-mediated 3-O-glucuronidation of natural flavonols using a pharmacophore-based comparative molecular field analysis model","volume":"336","author":"Wu","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.toxlet.2018.05.008_bib0175","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.phrs.2016.05.013","article-title":"Drug interaction study of natural steroids from herbs specifically toward human UDP-glucuronosyltransferase (UGT) 1A4 and their quantitative structure activity relationship (QSAR) analysis for prediction","volume":"110","author":"Xu","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.toxlet.2018.05.008_bib0180","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11130-004-0049-7","article-title":"Flavonoids in food and their health benefits","volume":"59","author":"Yao","year":"2004","journal-title":"Plant Foods Hum. Nutr."},{"key":"10.1016\/j.toxlet.2018.05.008_bib0185","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11130-004-0049-7","article-title":"Flavonoids in food and their health benefits","volume":"59","author":"Yao","year":"2004","journal-title":"Plant Foods Hum. Nutr"},{"key":"10.1016\/j.toxlet.2018.05.008_bib0190","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/j.xphs.2017.04.004","article-title":"Intestinal drug interactions mediated by OATPs: a systematic review of pre-clinical and clinical findings","volume":"106","author":"Yu","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.toxlet.2018.05.008_bib0195","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2174\/187231210791698483","article-title":"Evaluation of cytochrome P450 inhibition assays using human liver microsomes by a cassette analysis \/LC-MS\/MS","volume":"4","author":"Zambon","year":"2010","journal-title":"Drug Metab. Lett."}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427418301917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427418301917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T23:41:34Z","timestamp":1544226094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427418301917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":39,"alternative-id":["S0378427418301917"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2018.05.008","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug interaction study of flavonoids toward CYP3A4 and their quantitative structure activity relationship (QSAR) analysis for predicting potential effects","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2018.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}